SDIX, OriGene’s wholly owned subsidiary, has manufactured OriGene’s antibodies, including UltraMAB®, in a GMP environment and obtained CE marking for these products. The CE marking provides a level of quality, safety and performance to ensure product reliability and reproducibility. The antibodies are intended for detection of specific protein expression in frozen or formalin fixed human tissues and cells. These antibodies are for in vitro diagnostic (IVD) use*.
* The clinical interpretation of any positive staining or its absence should be complemented by morphological and histological studies with proper controls. Evaluations should be made within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.
Figure 1. IHC screening presenting three new CE marked Antibodies. Panel 1 demonstrates anti-ALK staining of NSCLC; Panel 2 illustrates anti-Her2 staining of breast cancer; Panel 3 shows anti-Ki-67 staining of tonsil tissue. Antibodies were incubated on HIER pretreated paraffin embedded tissue at 1:100 (ALK and Her2) or 1:200 (Ki-67) dilution for 30 minutes at room temperature. Detection was done with RTU polymer detection kit (POLINK-2 Broad HRP) and signal shown DAB chromogen.